XZXiao Zhang

Xiao Zhang

*This is an algorithmically generated author record based on publicly available information.

Xiao Zhang has a total of 10 co-authors. Here are the top co-authors by number of shared publications:

  • Bin Song

    Department of Radiology, West China Hospital, Sichuan University, Chengdu, China

    1 shared publication
  • Fubi Hu

    Department of Radiology, First Affiliated Hospital of Chengdu Medical College, Chengdu, China

    1 shared publication
  • Hongxi Chen

    Department of Radiology, West China Clinical Medical College of Sichuan University, Chengdu, China

    1 shared publication
  • Jianyu Li

    Department of Radiology, Huaxi MR Research Center (HMRRC), Institute of Radiology and Medical Imaging, West China Hospital of Sichuan University, Chengdu, China

    1 shared publication
  • Longbin Zhang

    Department of Cancer Center, Chongqing University Three Gorges Hospital, Chongqing, China

    1 shared publication
  • Min Zhang

    Clinical Research Center, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, China

    1 shared publication

Latest Publications

  • Open Access

    Interpretable Prediction Model for Short-Term and Long-Term Hepatic Encephalopathy and Variceal Rebleeding After Transjugular Intrahepatic Portosystemic Shunt: A Real-World Study

    by Shang Wan, Longbin Zhang, Jianyu Li, Hongxi Chen, Min Zhang, Xiao Zhang, Bin Song

    INTRODUCTION: Transjugular intrahepatic portosystemic shunt (TIPS) relieves portal hypertension, but post-TIPS overt hepatic encephalopathy (OHE) and variceal rebleeding (VRB) remain outcomes that significantly impair survival. The aim of this study was to identify risk factors and develop an interpretable machine learning model predicting 2-year and 6-year OHE and VRB. METHODS: In this multicenter retrospective study, 636 patients undergoing TIPS (2014–2023) with 2–6 years follow-up were analyzed. A detailed perioperative data set was curated. Least Absolute Shrinkage and Selection Operator selected key predictors for model training in an integrated machine learning voting ensemble (ML-VE) framework. Efficacy was assessed by area under the receiver operating characteristic curve (AUC) and compared with conventional clinical scores (Child-Pugh, MELD, and MELD-Na). Subgroup analyses were conducted, and Shapley Additive Explanations were used for interpretation. RESULTS: The cumulative incidences of OHE and VRB were 22.2% and 8.2% at 2 years, respectively, increasing to 24.8% and 10.1% at 6 years. Internally, ML-VE achieved AUCs of 0.960 (OHE) and 0.966 (VRB) at 2 years and 0.849 (OHE) and 0.828 (VRB) at 6 years. External validation for OHE yielded AUCs of 0.914 at 2 years and 0.924 at 6 years, outperforming conventional scores (AUC 0.528–0.563 for OHE; 0.528–0.555 for VRB). All prespecified subgroups had 2-year AUCs ≥0.93 (OHE prediction in portal vein thrombosis: 0.993; VRB prediction in portal pressure gradient 9–12 mm Hg: 0.987). SHapley Additive exPlanationsidentified “diabetes” as the strongest predictor of OHE and “recent bleeding” as the strongest predictor of VRB at 2 years. DISCUSSION: The interpretable ML-VE model showed good discrimination for 2-year and 6-year post-TIPS OHE and VRB risk, suggesting potential utility for short-term and long-term risk stratification after TIPS.

  • A CT-based 2.5D deep learning model for preoperative T-staging in gastric cancer: a retrospective multicenter study

    by Ying Liu, Xiao Zhang, Wangyang He, Yang Li, Fubi Hu

    Purpose To develop and validate a 2.5D multi-angle deep learning (MADL) model for preoperative T-staging in patients with gastric cancer (GC) and to explore the predictive potential for survival outcome. Materials and methods In this retrospective study, GC datasets from four centers were used to develop a quaternary for preoperative T-staging model by integrating CT images with nine 2D slicers and three angles (0°, + 45°, -45°) from transverse, sagittal, and coronal views. Diagnostic performance (accuracy, sensitivity, specificity, F1-score) were compared between the 2.5D MADL and radiologists. The prognostic potential of 2.5D MADL-derived features was evaluated using Kaplan-Meier analysis and multivariate Cox regression. Results A total of 433 patients were divided into the training (n = 346, mean age, 64.8 years ± 10.5 [SD]; 95 female) and the internal validation (n = 87, mean age, 63.0 years ± 11.9; 23 female) sets from Centers 1–3, and 41 patients (mean age, 64.6 years ± 8.9; 10 female) formed the external testing set from Center 4. The 2.5D MADL model exhibited excellent diagnostic performance for T-staging in external testing set (AUCs of T1-T4: 0.962, 0.722, 0.913, 0.962). For T1 staging, it outperformed radiologists in accuracy (95% vs. 83%), sensitivity (75% vs. 12%), and F1 score (86% vs. 22%) in external testing set. Survival analysis showed significant overall survival differences between high- and low-risk groups stratified (P < 0.001), with high-risk patients having shorter survival (HR = 1.632, 95% CI:1.239–2.150). Conclusion The 2.5D MADL model achieves accurate and reliable preoperative T staging of gastric cancer, with performance comparable to radiologists and superior accuracy for early-stage disease.